Drug categories P
Drug Category Names, Results, and Descriptions
- Parasympatholytics (75) • Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
- Parasympathomimetics (18) • Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
- Parenteral Nutrition Solutions (5) • Specialized solutions for PARENTERAL NUTRITION. They may contain a variety of MICRONUTRIENTS; VITAMINS; AMINO ACIDS; CARBOHYDRATES; LIPIDS; and SALTS.
- Perfume (3) • A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. (Random House Unabridged Dictionary, 2d ed)
- Peroxisome Proliferators (3) • A class of nongenotoxic CARCINOGENS that induce the production of hepatic PEROXISOMES and induce hepatic neoplasms after long-term administration.
- Pesticide Synergists (3) • Chemicals that, while not possessing inherent pesticidal activity, nonetheless promote or enhance the effectiveness of other pesticides when combined.
- Pesticides (369) • Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc.
- Pharmaceutic Aids (27) • Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; COLORING AGENTS; FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES.
- Pharmaceutical Vehicles (11) • A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986)
- Phosphodiesterase 3 Inhibitors (5) • Compounds that specifically inhibit PHOSPHODIESTERASE 3.
- Phosphodiesterase 4 Inhibitors (7) • Compounds that specifically inhibit PHOSPHODIESTERASE 4.
- Phosphodiesterase 5 Inhibitors (9) • Compounds that specifically inhibit PHOSPHODIESTERASE 5.
- Phosphodiesterase Inhibitors (66) • Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.
- Photoaffinity Labels (5) • Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins.
- Photosensitizing Agents (42) • Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
- Phytoestrogens (14) • PLANT EXTRACTS and compounds, primarily ISOFLAVONES, that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS.
- Plant Growth Regulators (25) • Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins.
- Plasma Substitutes (5) • Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration.
- Plasticizers (4) • Materials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment.
- Platelet Aggregation Inhibitors (143) • Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
- Poisons (33) • Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed)
- Poly(ADP-ribose) Polymerase Inhibitors (17) • Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES.
- Potassium Channel Blockers (17) • A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.
- Preservatives, Pharmaceutical (7) • Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants.
- Progestins (16) • Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
- Prostaglandin Antagonists (12) • Compounds that inhibit the action of prostaglandins.
- Protease Inhibitors (235) • Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).
- Protective Agents (408) • Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent.
- Protein Kinase Inhibitors (70) • Agents that inhibit PROTEIN KINASES.
- Protein Synthesis Inhibitors (61) • Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.
- Proton Ionophores (3) • Chemical agents that increase the permeability of CELL MEMBRANES to PROTONS.
- Proton Pump Inhibitors (16) • Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.
- Provitamins (5)
- Psychotropic Drugs (318) • A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
Drug Category Names, Results, and Descriptions
- Top 200 drugs
- Medicare drugs
- Canadian drugs
- Dictionary of drugs
- Encyclopedia of drugs
- List of FDA approved drugs
- List of drugs A-Z - sorted in multipage format
- Drug categories
- Habit forming drugs
The following is the collection of detailed information and links to the National Institute of Health (NIH) comprehensive drug information portal and other reliable sources of information. Select the drug name below to show drug description, drug classification, other common drug names, and information on the reasons why prescribed, how medication should be used, and what possible side effects could occur.